Researchers analyzed data from a nationwide cohort to evaluate the effectiveness of covalent Bruton tyrosine kinase inhibitors, used either as monotherapy or in combination with anti-CD20 monoclonal...
A retrospective study highlights the safety and feasibility of outpatient administration of brexucabtagene autoleucel for patients with acute lymphoblastic leukemia and mantle cell lymphoma, showing...
In a prospective randomized controlled trial, researchers evaluated the effectiveness of virtual reality as a nonpharmacologic therapy for pain in hospitalized patients with cancer.
In a population-based, cross-sectional study, researchers examined US women aged 20 to 49 years who were diagnosed with primary invasive breast cancer from 2000 through 2019.
In a long-term follow-up to SIERRA, a multicenter, randomized, controlled phase 3 study, researchers found that patients 55 years of age or older with active relapsed or refractory acute myeloid leukemia...
Although the immunotherapy plus chemotherapy did not improve disease-free survival (DFS) in newly diagnosed, high-risk patients with endometrial cancer, the combination therapy did improve DFS for patients...
Researchers who developed a meta-analysis of 19 randomized controlled trials found a statistically significant improvement in overall survival with sorafenib when compared with placebo for patients with...
Researchers sought to determine the reliability of the use of transvaginal ultrasonography triage to diagnose endometrial cancer in patients who are Black and at risk for the disease.
Researchers conducted a cross-sectional clinical trial with 8920 participants to evaluate whether a multitarget stool RNA test could serve as a noninvasive tool for detecting colorectal cancer, offering an...
